Study models how ketamine’s molecular action leads to its effects on the brain
New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.
“Rosetta Stone” of cell signaling could expedite precision cancer medicine
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
School of Engineering welcomes new faculty
Fifteen new faculty members join six of the school’s academic departments.
Adhesive coatings can prevent scarring around medical implants
New adhesive hydrogel coatings could prolong the lifespan of pacemakers, drug delivery depots, and other medical devices.
The beauty of biology
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Navigating longevity with industry leaders at MIT AgeLab PLAN Forum
A symposium for financial professionals imagines a new industry around longevity planning.
From steel engineering to ovarian tumor research
Ashutosh Kumar, a materials science and engineering PhD student and MathWorks Fellow, applies his eclectic skills to studying the relationship between bacteria and cancer.
New treatment could reverse hair loss caused by an autoimmune skin disease
A microneedle patch that delivers immune-regulating molecules can teach T cells not to attack hair follicles, helping hair to regrow.
A closed-loop drug-delivery system could improve chemotherapy
New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.
A biomedical engineer pivots from human movement to women’s health
Postdoc Shaniel Bowen studies women's sexual anatomy and health while also working to interest young women in STEM careers.
Growing our donated organ supply
Graduate student Hammaad Adam is working to increase the supply of organs available for transplants, saving lives and improving health equity.
Improving drug development with a vast map of the immune system
Immunai’s founders were researchers at MIT when they launched their company to help predict how patients will respond to new treatments.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
For Julie Greenberg, a career of research, mentoring, and advocacy
The longtime academic leader of the Harvard-MIT Program in Health Sciences and Technology reflects on her time spent guiding students at the intersection of medicine and engineering.
Unlocking mRNA’s cancer-fighting potential
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.